Skip to content

DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial

DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05977218
Acronym
DIATEST-HELP
Enrollment
900
Registered
2023-08-04
Start date
2025-08-25
Completion date
2031-12-31
Last updated
2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Diet, Mobile health, HbA1c

Brief summary

This randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice alone. The primary outcome is change in HbA1c at 6 months; secondary outcomes include anthropometrics, quality of life, medication use, hospitalizations, and mortality.

Detailed description

A healthy diet improves glycaemic control and reduces cardiovascular risk in type 2 diabetes (T2D), but access to dietitians is limited. Unlike several countries, Sweden has not implemented interpretive front-of-pack labelling. Smartphone applications may offer an alternative. This trial evaluates the dietary and clinical impact of FoodSwitch, a mobile app providing interpretive labelling to Swedish adults with T2D. Nine hundred individuals with T2D for ≥2 years who regularly shop for groceries will be recruited via general practices and community advertisements and randomized to receive access to FoodSwitch plus standard written dietary advice, or standard written dietary advice only. The primary outcome is change in self-measured glycated haemoglobin (HbA1c) after 6 months. Secondary outcomes include waist circumference, body weight, quality of life, dietary self-efficacy, medication use, hospitalizations, and all-cause mortality. Exploratory outcomes include omics analyses.

Interventions

OTHERFoodSwitch

Access to the 'DiabetesSwitch' filter of the FoodSwitch app when grocery shopping. When a packaged food item bar code is scanned, the FoodSwitch app will show an interpretive nutritional information score for the scanned product and recommend alternate healthier food options in the same category.

Sponsors

Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 75 years * Self-reported type 2 diabetes with a duration of ≥2 years * Regularly grocery shopping

Exclusion criteria

* No access to BankID (a digital identification system commonly used in Sweden) * Failure to complete eligibility screening and run-in periods

Design outcomes

Primary

MeasureTime frameDescription
Mean HbA1cChange from baseline at week 26Mean glycated haemoglobin

Secondary

MeasureTime frameDescription
Self-measured waist circumference (cm)Change from baseline at week 26Self-measured waist circumference (cm)
Self-reported quality of lifeChange from baseline at week 26Self-reported quality of life - questionnaire
Self-measured body weight (kg)Change from baseline at week 26Self-measured body weight (kg)
Self-reported dietary self-efficacyChange from baseline at week 26Self-reported dietary self-efficacy
Difference in all-cause mortalityChange from baseline at week 26Difference in all-cause mortality
Registry-based data on medication use, hospitalizations, outpatient visits, and diabetes complicationsChange from baseline at week 26Registry-based data on medication use, hospitalizations, outpatient visits, and diabetes complications

Other

MeasureTime frameDescription
Dietary effects on proteomics and metabolomicsChange from baseline at week 26Dietary effects on proteomics and metabolomics

Countries

Sweden

Contacts

Primary ContactLana Hebib, MD
lana.hebib@liu.se013-28 10 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026